We found that ECs harbored not only known mutations in driver genes, such as ARID1A, CTNNB1, PIK3CA, and PTEN, but also novel mutations in cancer-related genes, such as KMT2C and PRKAR1A. This evidence concerns the gene KMT2C and cancer.